Summary

Market Overview
The Global Veterinary Pain Management Market is projected to grow from USD 3.15 Billion in 2025 to USD 4.95 Billion by 2031 at a 7.82% CAGR. This growth is largely fueled by a growing worldwide pet population and the rising trend of pet humanization, which encourages owners to spend more on high-quality veterinary services. In 2025, the American Veterinary Medical Association reported that households spent an average of $1,700 annually on their pets, with veterinary care representing 32.4% of those total costs.
At the same time, the increasing number of aging animals and the rising prevalence of chronic illnesses such as osteoarthritis are strongly driving the need for reliable pain relief therapies. However, market expansion faces a significant hurdle due to the high expenses tied to prolonged pain management treatments. These costs can create considerable financial strain for pet owners, especially in areas where pet insurance coverage remains low.
Market Driver
A primary catalyst for the Global Veterinary Pain Management Market is the surge in pet ownership and the growing tendency to treat animals as valued family members. This evolving mindset prompts owners to seek top-tier medical care, making them more inclined to fund advanced, long-term treatments, particularly for pain alleviation. Eager to improve their pets' comfort and overall well-being, owners are driving the need for a wide range of pain management options, spanning from medications to physical rehabilitation. Highlighting this financial dedication, a 2026 MetLife Pet Insurance survey revealed that owners spent an average of $2,360 on their pets in 2025. Ultimately, this deepened emotional connection leads to more frequent veterinary check-ups and strict compliance with care regimens, thereby boosting the demand for pain management offerings.
Furthermore, the rising occurrence of acute and chronic diseases in animals plays a crucial role in the escalating need for pain relief therapies. Enhanced nutrition and medical care have extended animal lifespans, making them more prone to age-related ailments, degenerative disorders, and acute conditions requiring robust pain management, including cancer and osteoarthritis. Demonstrating this trend, a March 2026 study by the University of Tennessee College of Veterinary Medicine noted that 60% of screened dogs aged four to ten exhibited radiographic evidence of osteoarthritis. This widespread disease prevalence highlights the ongoing requirement for sophisticated diagnostics and therapeutic interventions. Supporting this expanding sector, the American Pet Products Association's 2026 State of the Industry Report indicated that total U.S. pet industry spending reached $158 billion in 2025, emphasizing the vital nature of pain management within a thriving market.
Market Challenge
The substantial expenses linked to continuous pain management protocols pose a major obstacle to the expansion of the Global Veterinary Pain Management Market. Facing these financial burdens, pet owners are frequently forced into tough choices regarding their companions' healthcare, which can result in postponed or entirely skipped treatments. Consequently, the adoption rate of progressive and sustained pain relief solutions is directly hindered, even as the necessity for such care grows due to an older animal demographic and higher rates of chronic conditions.
Hesitation to commit to costly, ongoing treatment plans actively suppresses market growth. Highlighting this tangible barrier, the American Animal Hospital Association (AAHA) noted that nearly half of pet owners experienced financial worry over unforeseen veterinary bills in 2025, an increase from one in three in 2022. This demonstrates that economic realities often prevent owners from funding comprehensive pain management therapies, regardless of their deep emotional attachment to their pets. Ultimately, this financial strain slows the widespread implementation of both pharmaceutical and therapeutic interventions.
Market Trends
A prominent trend shaping the Global Veterinary Pain Management Market is the continuous advancement of drug formulations and delivery systems designed to enhance effectiveness and ease of use for both practitioners and pet owners. These developments are largely centered on producing extended-release pain medications, which improve animal well-being by lowering dosing frequency and boosting treatment compliance. Highlighting this progress, Zoetis received European Commission marketing authorization in October 2025 for Portela (relfovetmab), an innovative monoclonal antibody treatment that alleviates feline osteoarthritis pain with a convenient three-month dosing schedule. This milestone underscores a broader industry shift toward enduring pain control solutions that elevate animals' quality of life and encourage better adherence from their owners.
Simultaneously, targeted investments in cutting-edge therapeutic technologies are broadening the market's scope beyond traditional pharmaceuticals. This trend involves integrating diverse scientific disciplines and leveraging external partnerships to develop breakthrough solutions for chronic conditions. For instance, Boehringer Ingelheim's "Animal Health Partnering and Innovation Outlook 2026" detailed the company's objective to dedicate 30% of its research and development pipeline to external innovation; in 2025, this strategy included incorporating novel therapeutic vaccine technology specifically to address unmet needs in chronic pain. These strategic financial commitments drive the diversification of treatment methods, delivering highly targeted and sophisticated options for complex animal pain scenarios.

Key Market Players
* Boehringer Ingelheim International GmbH
* Zoetis Inc.
* Elanco Animal Health Incorporated
* Norbrook Laboratories Limited
* SeQuent Scientific Limited
* Merck & Co., Inc.
* Dechra Pharmaceuticals Plc
* Vetoquinol S.A.
* Ceva Sant? Animale SA
* Chanelle Pharma Group Ltd

Report Scope
In this report, the Global Veterinary Pain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

# Veterinary Pain Management Market, By Product
* Medications
* Medical Devices
# Veterinary Pain Management Market, By Application
* Joint Pain
* Cancer Pain
* Postoperative Pain
* Others
# Veterinary Pain Management Market, By Animal Type
* Companion Animal
* Livestock Animal
# Veterinary Pain Management Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Pain Management Market.
Available Customizations:
Global Veterinary Pain Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Veterinary Pain Management Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Medications, Medical Devices)
5.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
5.2.3. By Animal Type (Companion Animal, Livestock Animal)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Veterinary Pain Management Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Animal Type
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Veterinary Pain Management Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Animal Type
6.3.2. Canada Veterinary Pain Management Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Animal Type
6.3.3. Mexico Veterinary Pain Management Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Animal Type
7. Europe Veterinary Pain Management Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Animal Type
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Veterinary Pain Management Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Animal Type
7.3.2. France Veterinary Pain Management Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Animal Type
7.3.3. United Kingdom Veterinary Pain Management Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Animal Type
7.3.4. Italy Veterinary Pain Management Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Animal Type
7.3.5. Spain Veterinary Pain Management Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Animal Type
8. Asia Pacific Veterinary Pain Management Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Animal Type
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Veterinary Pain Management Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Animal Type
8.3.2. India Veterinary Pain Management Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Animal Type
8.3.3. Japan Veterinary Pain Management Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Animal Type
8.3.4. South Korea Veterinary Pain Management Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Animal Type
8.3.5. Australia Veterinary Pain Management Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Animal Type
9. Middle East & Africa Veterinary Pain Management Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Animal Type
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Veterinary Pain Management Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Animal Type
9.3.2. UAE Veterinary Pain Management Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Animal Type
9.3.3. South Africa Veterinary Pain Management Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Animal Type
10. South America Veterinary Pain Management Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Animal Type
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Veterinary Pain Management Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Animal Type
10.3.2. Colombia Veterinary Pain Management Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Animal Type
10.3.3. Argentina Veterinary Pain Management Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Animal Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Veterinary Pain Management Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Boehringer Ingelheim International GmbH
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Zoetis Inc.
15.3. Elanco Animal Health Incorporated
15.4. Norbrook Laboratories Limited
15.5. SeQuent Scientific Limited
15.6. Merck & Co., Inc.
15.7. Dechra Pharmaceuticals Plc
15.8. Vetoquinol S.A.
15.9. Ceva Sant? Animale SA
15.10. Chanelle Pharma Group Ltd
16. Strategic Recommendations
17. About Us & Disclaimer